Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor.
Tezuka Y, Sekine O, Hirano A, Hanada Y, Nakanishi I, Ariga M, Azuma C, Yamamoto Y, Ito-Kobayashi J, Washiyama M, Iwanishi M, Furuta M, Kanamori M, Shimatsu A, Kashiwagi A. Tezuka Y, et al. Among authors: azuma c. Diabetes Ther. 2021 Jan;12(1):431-440. doi: 10.1007/s13300-020-00950-7. Epub 2020 Oct 27. Diabetes Ther. 2021. PMID: 33108650 Free PMC article.
Clinical characteristics in two patients with partial lipodystrophy and Type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene.
Iwanishi M, Kusakabe T, Azuma C, Tezuka Y, Yamamoto Y, Ito-Kobayashi J, Washiyama M, Morimoto M, Ebihara K. Iwanishi M, et al. Among authors: azuma c. Diabetes Res Clin Pract. 2019 Jun;152:79-87. doi: 10.1016/j.diabres.2019.04.034. Epub 2019 May 16. Diabetes Res Clin Pract. 2019. PMID: 31102683
Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1.
Iwanishi M, Azuma C, Tezuka Y, Yamamoto Y, Ito-Kobayashi J, Washiyama M, Kusakabe T, Kikugawa S. Iwanishi M, et al. Among authors: azuma c. Intern Med. 2020;59(20):2529-2537. doi: 10.2169/internalmedicine.4042-19. Epub 2020 Oct 15. Intern Med. 2020. PMID: 33055470 Free PMC article.
Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients.
Yamamoto Y, Ozamoto Y, Kobayashi M, Tezuka Y, Azuma C, Sekine O, Ito-Kobayashi J, Washiyama M, Oe Y, Iwanishi M, Togawa T, Hagiwara A, Kitamura T, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: azuma c. Endocr J. 2022 Jun 28;69(6):689-703. doi: 10.1507/endocrj.EJ21-0615. Epub 2022 Jan 27. Endocr J. 2022. PMID: 35082201 Free article.
The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.
Yamamoto Y, Togawa T, Sekine O, Ozamoto Y, Fuse J, Azuma C, Ito-Kobayashi J, Oe Y, Hagiwara A, Kobayashi M, Kitamura T, Iwanishi M, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: azuma c. Endocr J. 2023 Dec 28;70(12):1141-1157. doi: 10.1507/endocrj.EJ23-0241. Epub 2023 Oct 17. Endocr J. 2023. PMID: 37853621 Free article.
Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Yukishima T, Furuhashi K, Shimoyama K, Taki T, Azuma C, Yamazaki K, Furukawa S, Fukami S, Nagura O, Katahashi K, Yamashita K, Maekawa M, Ogawa N. Yukishima T, et al. Among authors: azuma c. J Infect Chemother. 2024 Sep;30(9):922-927. doi: 10.1016/j.jiac.2024.02.004. Epub 2024 Feb 10. J Infect Chemother. 2024. PMID: 38342142
Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement.
Tsuji K, Kobayakawa T, Ishii T, Higashi-Kuwata N, Azuma C, Shinohara K, Miura Y, Yamamoto K, Nishimura S, Hattori SI, Bulut H, Mitsuya H, Tamamura H. Tsuji K, et al. Among authors: azuma c. Chem Pharm Bull (Tokyo). 2023;71(12):879-886. doi: 10.1248/cpb.c23-00562. Chem Pharm Bull (Tokyo). 2023. PMID: 38044140 Free article.
194 results